2016 | Safety and efficacy of pregabalin in adolescents with fibromyalgia: A randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study | Arnold L.M.; Schikler K.N.; Bateman L.; Khan T.; Pauer L.; Bhadra-Brown P.; Clair A.; Chew M.L.; Scavone J.; Alario A.; Babhulkar S.S.; Berenguer R.; Freeman P.; Gold J.; Goodman S.; Jarosova H.; Lee W.; Liss J.; Lvovich S.; Maiquez A.; Morcos N.; Nellikunja S.; Passo M.; Schanberg L.; Sharma V.P.; Spencer C.; Toth M.; Veeravalli S.C.M.; WEN-CHIN WENG ; on behalf of the Pregabalin Adolescent Fibromyalgia Study Group | Pediatric Rheumatology | 30 | 32 | |